Superbug infections tracked across Europe

For the first time, scientists have shown that MRSA and other antibiotic-resistant 'superbug' infections can be tracked across Europe. In a study published in the journal mBio, researchers at Imperial College London and the Wellcome Trust Sanger Institute worked with a European network representing doctors in 450 hospitals in 25 countries to successfully interpret and visualise the spread of drug-resistant MRSA. The team combined whole-genome sequencing with a web-based system MRSA (meticillin-resistant Staphylococcus aureus) and other superbugs are a life-threatening problem for all hospitals across Europe with an estimated 400,000 cases per year and 25,000 deaths from resistant, hospital-acquired infections. To enable infection control teams across Europe to easily share information and to form a dynamic picture of the rise and spread of antibiotic-resistant bacteria, the scientists from the newly formed Centre for Genomic Pathogen Surveillance developed Microreact.org , a web-based visualisation and mapping tool. Dr David Aanensen , head of the Centre for Genomic Pathogen Surveillance and lead author on the paper said: "Drug resistance is a growing problem both in Europe and across the world and doctors need fast and accurate information to stop epidemics. Our study demonstrates the potential for combining whole-genome sequencing with internet-based visualisation tools to enable public health workers and doctors to see how an epidemic is spreading and make swift decisions to end it." The research team read the whole genomes of S. aureus samples to identify which bugs are related to each other, and which are resistant to antibiotics.